Attached files
file | filename |
---|---|
10-K - ANNUAL REPORT - SCIVANTA MEDICAL CORP | f10k2010_scivanta.htm |
EX-31.1 - SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER. - SCIVANTA MEDICAL CORP | f10k2010ex31i_scivanta.htm |
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - SCIVANTA MEDICAL CORP | f10k2010ex21i_scivanta.htm |
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350. - SCIVANTA MEDICAL CORP | f10k2010ex32ii_scivanta.htm |
EX-31.2 - SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER. - SCIVANTA MEDICAL CORP | f10k2010ex31ii_scivanta.htm |
EX-10.8 - AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENT BETWEEN THE REGISTRANT AND THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK FOR AND ON BEHALF OF UNIVERSITY OF BUFFALO, AND DONALD D. HICKEY, M.D. AND CLAS E. LUNDGREN DATED FEBRUARY 14, 2011 - SCIVANTA MEDICAL CORP | f10k2010ex10viii_scivanta.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Scivanta Medical Corporation (the “Company”) on Form 10-K for the fiscal year ended October 31, 2010, as filed with the Securities and Exchange Commission (the “Report”), I, David R. LaVance, President and Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)
|
the Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, 15 U.S.C. §78m or 78o(d), and,
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: February 15, 2011 By: /s/ David R. LaVance
David R. LaVance
President and Chief Executive Officer